Tag: GMP Active Pharmaceutical Ingredient
Patient-ready MDMA lands in Australia for GMP standard manufacturing
Australian medicinal cannabis company Vitura Health Limited has released an update on its Cortexa Joint Venture with PharmAla Biotech after landing bulk GMP Active Pharmaceutical Ingredient (API) for MDMA (3,4-Methylenedioxy-methamphetamine) in Australia.
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
